col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


48 Results       Page 1

 [1] 
EMBO: EMBO Molecular Medicine
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―12 An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV -2 Lianghui Zhang, Krishna K. Narayanan, Laura Cooper, Kui K. Chan, Savanna S. Skeeters, Christine A. Devlin, et al. (+6)
2 [GO] 2022―Aug―20 A universal SARS-CoV DNA vaccine inducing highly crossreactive neutralizing antibodies and T cells Sofia Appelberg, Gustaf Ahlén, Jingyi Yan, Negin Nikouyan, Sofie Weber, Olivia Larsson, et al. (+14)
3 [GO] 2022―Jul―27 SARS-CoV -2 spike protein enhances MAP4K3 / GLK -induced ACE2 stability in COVID -19 Huai-Chia Chuang, Chia-Hsin Hsueh, Pu-Ming Hsu, Rou-Huei Huang, Ching-Yi Tsai, Nai-Hsiang Chung, et al. (+2)
4 [GO] 2022―Jul―04 Clinical grade ACE2 as a universal agent to block SARS-CoV -2 variants Vanessa Monteil, Brett Eaton, Elena Postnikova, Michael Murphy, Benedict Braunsfeld, Ian Crozier, et al. (+29)
5 [GO] 2022―Jul―04 Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination Sebastian J Theobald, Alexander Simonis, Julie M Mudler, Ulrike Göbel, Richard Acton, Viktoria Kohlhas, et al. (+9)
6 [GO] 2022―Jul―01 A novel platform for attenuating immune hyperactivity using EXO-CD24 in Covid-19 and beyond Shiran Shapira, Marina Ben Shimon, Mori Hay-Levi, Gil Shenberg, Guy Choshen, Lian Bannon, et al. (+9)
7 [GO] 2022―May―17 Olverembatinib inhibits SARS-CoV-2-Omicron variant-mediated cytokine release in human peripheral blood mononuclear cells Marina Chan, Eric C Holland, Taranjit S Gujral
8 [GO] 2022―Apr―01 SARS-CoV-2 Spike Spurs Intestinal Inflammation via VEGF Production in Enterocytes Fa-min Zeng, Ying-wen Li, Zhao-hua Deng, Jian-zhong He, Wei Li, Lijie Wang, et al. (+12)
9 [GO] 2022―Mar―14 RNAi to treat SARS-CoV-2-variant proofing the next generation of therapies Nigel A J McMillan, Kevin V Morris, Adi Idris
10 [GO] 2022―Feb―25 COVID-19 vaccination, time for a second breath? Christiane E Gerke, Bernd Pulverer, Philippe J Sansonetti
11 [GO] 2022―Feb―09 A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant Yi-Chung Chang, Chi-Fan Yang, Yi-Fen Chen, Chia-Chun Yang, Yuan-Lin Chou, Hung-Wen Chou, et al. (+18)
12 [GO] 2022―Jan―27 SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance Xavier Montagutelli, Sylvie van der Werf, Felix A Rey, Etienne Simon-Loriere
13 [GO] 2022―Jan―07 Decreased memory B cells frequencies in COVID-19 Delta variant vaccine breakthrough infection Matthew Zirui Tay, Angeline Rouers, Siew-Wai Fong, Yun Shan Goh, Yi-Hao Chan, Zi Wei Chang, et al. (+24)
14 [GO] 2021―Dec―04 Predicting Infectivity: Comparing Four PCR-based Assays to Detect Culturable SARS-CoV-2 in Clinical Samples Emily A. Bruce, Margaret G. Mills, Reigran Sampoleo, Garrett A. Perchetti, Meei-Li Huang, Hannah W. Despres, et al. (+6)
15 [GO] 2021―Nov―08 High levels of circulating osteopontin in inflammatory lung disease regardless of SARS-CoV-2 infection Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti
16 [GO] 2021―Oct―21 Flower lose, a cell fitness marker, predicts COVID-19 prognosis Michail Yekelchyk, Esha Madan, Jochen Wilhelm, Kirsty R Short, António M Palma, Linbu Liao, et al. (+37)
17 [GO] 2021―Oct―21 Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody Tingting Li, Hongmin Cai, Yapei Zhao, Yanfang Li, Yanling Lai, Hebang Yao, et al. (+29)
18 [GO] 2021―Oct―16 Brain Cross-Protection against SARS-CoV-2 Variants by a Lentiviral Vaccine in New Transgenic Mice Min-Wen Ku, Pierre Authié, Maryline Bourgine, François Anna, Amandine Noirat, Fanny Moncoq, et al. (+15)
19 [GO] 2021―Sep―17 Racing for a SARS-CoV-2 vaccine Özlem Türeci, Uğur Şahin
20 [GO] 2021―Jul―14 Individual COVID-19 disease trajectories revealed by plasma proteomics Danish Memon, Inigo Barrio-Hernandez, Pedro Beltrao
21 [GO] 2021―Jul―07 High-resolution serum proteome trajectories in COVID-19 reveal patient-specific seroconversion Philipp E Geyer, Florian M Arend, Sophia Doll, Marie-Luise Louiset, Sebastian Virreira Winter, Johannes B Müller-Reif, et al. (+8)
22 [GO] 2021―Jun―25 Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin Guilherme Dias de Melo, Françoise Lazarini, Florence Larrous, Lena Feige, Etienne Kornobis, Sylvain Levallois, et al. (+9)
23 [GO] 2021―Jun―16 Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19 Sebastian J Theobald, Alexander Simonis, Theodoros Georgomanolis, Christoph Kreer, Matthias Zehner, Hannah S Eisfeld, et al. (+27)
24 [GO] 2021―May―09 Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2 Yi-Hao Chan, Siew-Wai Fong, Chek-Meng Poh, Guillaume Carissimo, Nicholas Kim-Wah Yeo, Siti Naqiah Amrun, et al. (+20)
25 [GO] 2021―May―01 SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course Study - Potential Challenge for Vaccines and Therapies Stefanie Weber, Christina M. Ramirez, Barbara Weiser, Harold Burger, Walter Doerfler
26 [GO] 2021―Mar―31 High levels of circulating osteopontin in inflammatory lung disease regardless of Sars-CoV-2 infection Giuseppe Cappellano, Hugo Abreu, Davide Raineri, Lorenza Scotti, Luigi Castello, Rosanna Vaschetto, Annalisa Chiocchetti
27 [GO] 2021―Feb―06 Epithelial response to IFN-γ promotes SARS-CoV-2 infection Julian Heuberger, Jakob Trimpert, Daria Vladimirova, Christian Goosmann, Manqiang Lin, Rosa Schmuck, et al. (+5)
28 [GO] 2021―Jan―20 Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein Lydia Horndler, Pilar Delgado, David Abia, Ivaylo Balabanov, Pedro Martínez-Fleta, Georgina Cornish, et al. (+6)
29 [GO] 2020―Dec―17 The riddle of the Sphinx: why sphingosine-1-phosphate may help define molecular mechanisms underlying risk stratification for serious COVID-19 infections Hugh Rosen, Michael B A Oldstone
30 [GO] 2020―Nov―15 Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19 Giovanni Marfia, Stefania Navone, Laura Guarnaccia, Rolando Campanella, Michele Mondoni, Marco Locatelli, et al. (+9)
31 [GO] 2020―Nov―12 Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection Vanessa Monteil, Matheus Dyczynski, Volker M Lauschke, Hyesoo Kwon, Gerald Wirnsberger, Sonia Youhanna, et al. (+7)
32 [GO] 2020―Nov―07 Humanized COVID-19 decoy antibody effectively blocks viral entry and prevents SARS-CoV-2 infection Kuo-Yen Huang, Ming-Shiu Lin, Ting-Chun Kuo, Ci-Ling Chen, Chung-Chih Lin, Yu-Chi Chou, et al. (+7)
33 [GO] 2020―Oct―20 Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia Lara Gibellini, Sara De Biasi, Annamaria Paolini, Rebecca Borella, Federica Boraldi, Marco Mattioli, et al. (+14)
34 [GO] 2020―Oct―19 COVID -19 pandemic-related lockdown: response time is more important than its strictness Gil Loewenthal, Shiran Abadi, Oren Avram, Keren Halabi, Noa Ecker, Natan Nagar, et al. (+2)
35 [GO] 2020―Oct―05 A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2 Alexander Simonis, Sebastian J. Theobald, Gerd Fätkenheuer, Jan Rybniker, Jakob J. Malin
36 [GO] 2020―Oct―04 SARS-CoV-2 outbreak investigation in a German meat processing plant Thomas Günther, Manja Czech-Sioli, Daniela Indenbirken, Alexis Robitaille, Peter Tenhaken, Martin Exner, et al. (+4)
37 [GO] 2020―Sep―30 COVID-19: A Pandemic Experience that Illuminates Potential Reforms to Health Research Hannah N. Kozlowski, Michael E. Farkouh, Meredith S. Irwin, Laszlo G. Radvanyi, Aaron D. Schimmer, Uri Tabori, Norman D. Rosenblum
38 [GO] 2020―Aug―20 Monocytopenia, monocyte morphological anomalies and hyperinflammation characterise severe COVID-19 in type 2 diabetes Fawaz Alzaid, Jean-Baptiste Julla, Marc Diedisheim, Charline Potier, Louis Potier, Gilberto Velho, et al. (+9)
39 [GO] 2020―Jun―23 Can artificial intelligence identify effective COVID-19 therapies? Michael B. Schultz, Daniel Vera, David A. Sinclair
40 [GO] 2020―Jun―19 Rationale for targeting Complement in COVID-19 Anastasia Polycarpou, Mark Howard, Conrad A Farrar, Roseanna Greenlaw, Giorgia Fanelli, Russell Wallis, et al. (+2)
41 [GO] 2020―Jun―19 Autopsy registry can facilitate COVID-19 research Saskia von Stillfried, Roman David Bülow, Rainer Röhrig, Ruth Knüchel-Clarke, Peter Boor
42 [GO] 2020―May―30 Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients Justin Stebbing, Venkatesh Krishnan, Stephanie de Bono, Silvia Ottaviani, Giacomo Casalini, Peter J. Richardson, et al. (+16)
43 [GO] 2020―May―19 The role of interleukin-6 in monitoring severe case of coronavirus disease 2019 Tao Liu, Jieying Zhang, Yuhui Yang, Hong Ma, Zhenyu Li, Jiaoyue Zhang, et al. (+7)
44 [GO] 2020―May―07 Is BCG vaccination causally related to reduced COVID-19 mortality? Masayuki Miyasaka
45 [GO] 2020―May―06 ‘All In’: A Pragmatic Framework for COVID-19 Testing and Action on a Global Scale SD Pettit, KR Jerome, D Rouquie, B Mari, P Barbry, Y Kanda, et al. (+5)
46 [GO] 2020―Apr―25 COVID-19: lambda interferon against viral load and hyperinflammation Evangelos Andreakos, Sotirios Tsiodras
47 [GO] 2020―Apr―20 COVID-19, chronicle of an expected pandemic Philippe Sansonetti
48 [GO] 2020―Apr―17 The prospects for the SARS-CoV-2 pandemic in Africa Virginia Quaresima, Matteo M. Naldini, Daniela M. Cirillo
 [1] 

48 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.006 sec